Nektar Therapeutics
Polymer-semaxanib moiety conjugates

Abstract:

The invention relates to (among other things) polymer-semaxanib moiety conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over the semaxanib moiety in unconjugated form.